(0.30%) 5 115.01 points
(0.30%) 38 353 points
(0.35%) 15 983 points
(-0.97%) $83.04
(5.25%) $2.02
(0.27%) $2 353.60
(0.54%) $27.68
(4.28%) $961.55
(-0.26%) $0.932
(-0.43%) $10.98
(-0.58%) $0.796
(1.63%) $93.37
Live Chart Being Loaded With Signals
Artelo Biosciences, Inc., a clinical stage biopharmaceutical company, focuses on developing and commercializing treatments to modulate the endocannabinoid system...
Stats | |
---|---|
本日の出来高 | 5 102.00 |
平均出来高 | 14 977.00 |
時価総額 | 4.38M |
EPS | $0 ( 2024-03-29 ) |
次の収益日 | ( $-1.050 ) 2024-06-28 |
Last Dividend | $0 ( N/A ) |
Next Dividend | $0 ( N/A ) |
P/E | -0.430 |
ATR14 | $0.0210 (1.60%) |
Date | Person | Action | Amount | type |
---|---|---|---|---|
2024-02-28 | Favorito Tamara A | Buy | 2 000 | Stock Option (right to buy) |
2024-02-28 | Favorito Tamara A | Buy | 1 083 | Stock Option (right to buy) |
2024-02-28 | Favorito Tamara A | Buy | 667 | Stock Option (right to buy) |
2024-02-28 | Favorito Tamara A | Sell | 1 083 | Stock Option (right to buy) |
2024-02-28 | Favorito Tamara A | Sell | 2 000 | Stock Option (right to buy) |
INSIDER POWER |
---|
15.97 |
Last 100 transactions |
Buy: 2 033 762 | Sell: 346 866 |
Artelo Biosciences Inc 相関
10 最も正の相関 | |
---|---|
CENT | 0.916 |
RLAY | 0.912 |
KNTE | 0.907 |
GOODO | 0.905 |
CENTA | 0.897 |
SLDP | 0.895 |
VERB | 0.889 |
CSTR | 0.884 |
CDW | 0.881 |
NTRS | 0.879 |
10 最も負の相関 | |
---|---|
NOVV | -0.898 |
ASLN | -0.887 |
SOUN | -0.86 |
QRTEP | -0.857 |
LTRY | -0.853 |
RPHM | -0.851 |
XOG | -0.85 |
OMER | -0.85 |
DHC | -0.846 |
ZGNX | -0.845 |
知っていましたか?
相関は、2つの変数間の関係を説明する統計的指標です。相関係数は-1から1までの値を取り、-1は完全な負の相関(1つの変数が増加すると、もう一方は減少する)、1は完全な正の相関(1つの変数が増加すると、もう一方も増加する)、0は相関がないことを示します(変数間に関係がない)。
相関は、株式だけでなく、どの2つの変数間の関係にも適用できます。これは、金融、経済学、心理学などの分野で一般的に使用されています。
Artelo Biosciences Inc 財務諸表
Annual | 2022 |
収益: | $0 |
総利益: | $0 (0.00 %) |
EPS: | $-3.49 |
FY | 2022 |
収益: | $0 |
総利益: | $0 (0.00 %) |
EPS: | $-3.49 |
FY | 2021 |
収益: | $0.00 |
総利益: | $0.00 (0.00 %) |
EPS: | $-0.400 |
FY | 2020 |
収益: | $0.00 |
総利益: | $0.00 (0.00 %) |
EPS: | $-1.260 |
Financial Reports:
No articles found.
Artelo Biosciences Inc
Artelo Biosciences, Inc., a clinical stage biopharmaceutical company, focuses on developing and commercializing treatments to modulate the endocannabinoid system. Its product candidate pipeline includes ART27.13, a synthetic G protein-coupled receptor agonist, which is in Phase 1b/2a clinical trial for the treatment of anorexia associated with cancer; ART12.11, a synthetic cannabidiol cocrystal for the treatment of inflammatory bowel disease and post-traumatic stress disorder (PTSD); and ART26.12, a fatty acid binding protein 5 inhibitor for prostate and breast cancer treatment, as well as for treating PTSD. Artelo Biosciences, Inc. has research collaboration with Trinity College Dublin to investigate ART27.13 for the treatment of cancer cachexia. The company was formerly known as Reactive Medical, Inc. and changed its name to Artelo Biosciences, Inc. in April 2017. Artelo Biosciences, Inc. was incorporated in 2011 and is based in Solana Beach, California.
について ライブシグナル
このページで提示されるライブシグナルは、NA を買う時や売る時を判断するのに役立ちます。シグナルには1分以上の遅延があります。市場シグナルには誤りやミスの可能性があるため、ライブ取引シグナルは決定的ではなく、getagraph.comはこれらのシグナルに基づく任意の行動について責任を負いません。詳細については、利用規約で説明されているように、技術分析指標に基づいています。